Chagee Holdings Limited (“Chagee” or the “Company”), a leading premium tea drinks brand serving healthy and delicious freshly-made tea drinks, today announced the pricing of its initial public ...

SYDNEY (Reuters) - Chinese tea firm Chagee has raised $411 million by setting the price of its shares at $28 each in its New ...

The Abu Dhabi health care company M42 is to make an investment in biotech longevity specialist Juvenescence as a route to moving into drug discovery and development, with the two forming a partnership ...

If US-listed Chinese shares return to the Hong Kong equity market for dual or secondary listings, Morgan Stanley said, the ...

Antibody-drug conjugate developer Duality Biotherapeutics Inc. debuted on the Hong Kong Stock Exchange (HKEX) with a HK$1.64 billion (US$211.4 million) IPO April 15, making it one of the biggest ...

The maker of traditional Chinese medicines has applied for a Hong Kong IPO after abandoning two listing attempts on China's domestic A-share market. Key Takeaways: Neautus has app ...

Duality Biotherapeutics stock more than doubled on its Hong Kong debut on Tuesday, achieving the best first-day trading ...

Shares of Duality Biotherapeutics surged on their Hong Kong debut after the massive oversubscription to the drug company's initial public offering. The shares rose 125% to 212.60 Hong Kong dollars in ...

By Scott Murdoch and Donny Kwok SYDNEY (Reuters) -Duality Biotherapeutics stock more than doubled on its Hong Kong debut on Tuesday, after the Chinese firm raised $213 million in an initial public ...

Duality Biologics, a Chinese antibody-drug conjugates startup, to go public on Hong Kong Stock Exchange with $194M IPO amid strong biotech sector performance.

Dreamland Limited targets a $9M US IPO despite financial instability. Read the full IPO report on TDIC stock here on Seeking Alpha.

After finding a strong audience for its stock among domestic investors, the functional beverage maker aims to offer its stock ...